20
Alembic Pharmaceuticals Limited Vadodara In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Clarithromycin, Process II, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2016-294 - Rev 00
This Chemical Type CEP, issued on July 26, 2018, remains in force until February 21, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1651 associated with this CEP further emphasizes